216 CHIMIA 2013, 67, Nr. 4
Laureates: awards and Honors, sCs FaLL Meeting 2012
and mode m/z (amu) [% relative base peak (ESI): (m/z): calcd for C35H44N4O7S+H: product was purified by HPLC ((XTerra
(100%)]. Semi-preparative HPLC was 665.3009, found: 665.3010. [α]D25 = 0.1 (c Prep RP C18, (25×150 mm Waters)) to
performed on a Waters Autopurification = 0.1, DCM).
ZQ System equipped with a 2767 Sample
Manager, a 2525 Binary Gradient Module 5-[(6-Aminohexyl)carbamoyl]ben-
and a 2996 Photodiode Array Detector, zene-1,2,3-triyl Triacetate (7)
give 8 (10 mg, 38%). IR (film): 3275,
2935, 1695, 2595, 1515, 1450, 1330, 1200,
1135, 1035, 865, 755, 720, 645, 585 cm–1.
1H NMR (400 MHz, MeOD): δ = 7.38 (d,
coupled toWaters Micromass ZQ analyzer.
The HPLC purifications were performed
Few drops of DMF were added to 1H, aromatic, CH), 7.37–7.29 (m, 7H,
3,4,5-triacetoxy benzoic acid (1 g, 3.4 aromatics, (CH)7), 6.82 (s, 2H, (CH)2),
2
on XTerra Prep RP C18 (19 × 150 mm)
mmol, 1 equiv.) in dry DCM (6 mL). The 5.42 (m, 1H, C(1’)H), 3.22 (dd, 1H, J =
3
2
columns, using reverse-phase conditions (2 reaction was cooled to 0 °C and oxalyl- 15.0 J = 2.0 Hz, CH2), 3.11 (t, 2H, J =
to 100% acetonitrile with 0.1% TFA over
chloride (0.31 mL, 3.7 mmol, 1.5 equiv.) 2.0 Hz, CH ), 2.82 (dd, 1H, 2J = 15.0 3J =
20 min). MS: Nermag R-10-10C, chemical was added drop wise. After 15 min the 3.8 Hz, CH22), 1.60–1.29 (m, 10H, 5 CH2).
ionization (NH3) mode m/z (amu) [% rela- reaction mixture was allowed to reach rt 13C NMR (100 MHz, MeOD): δ = 169.12,
tive base peak (100%)].
and stirred for 1 h. The solution was con- 156.64, 152.34, 151.03, 136.52, 129.57,
centrated under reduced pressure and the 127.92, 127.81, 126.89, 126.84), 125.74,
residue was suspended in dry DCM (4.5 125.48, 124.99, 123.47, 112.39, 109.57,
11,12-Didehydro-5,6-
dihydrodibenzo[a,e][8]annulen-5-yl mL). A solution containing N-Boc-1,6- 76.40, 45.74, 40.28, 39.36, 29.40, 29.10,
4-nitrophenyl Carbonate (2)
hexadiamine (0.72 g, 3.4 mmol, 1 equiv.) 26.25, 26.06. MS (ESI): HRMS (ESI):
4-Nitrophenyl chloroformate (0.9 g, and DIPEA (1.73 mL, 10.1 mmol, 3 equiv.) (m/z): calcd for C H30N2O +H: 515.2182,
4.6 mmol, 2 equiv.) and pyridine (0.9 mL, in DCM (4.5 mL) was added drop wise at 0 found: 515.2180. 3[0α]D = 60.1 (c = 0.004,
25
11.4, 5 equiv.) were added to a solution of °C. After 15 min the reaction mixture was CH2Cl2).
11,12-didehydro-5,6-dihydrodibenzo[a,e] allowed to reach room temperature and
[8]annulen-5-ol (1, 0.5 g, 3.6 mmol, 1 stirred for 1 h. The solution was concentrat-
equiv.) in DCM (68 mL) and the reaction ed under reduced pressure and the residue Bioceramics
mixture was stirred for 8 h at 25 °C. The so- was purified by flash column chromatogra- Discs (d = 2.5 cm, h = 0.5 cm) of dense-
lution was washed with brine (2 × 23 mL). phy (AcOEt/EP 1:1). The resulting product ly sintered HA and TCP biomaterials were
Coating of HA and TCP
The organic phase was dried with MgSO
was dissolved in 4 M HCl in dioxane and incubated in a solution of 8 at increasing
and concentrated under reduced pressure4. stirred for 1 h at room temperature. HCl concentrations (0, 5 and 10 µM) for 24 h at
The crude product was then purified by
was coevaporated three times with diethyl room temperature in the dark under slight
flash column chromatography (PE/DCM ether to afford a white paste (400 mg, 30% stirring. The discs were washed three times
2:1) to give 2 as a white solid (0.8 g, 88%). for 2 steps). IR (film): 3265, 2935, 2860, with water and dried under vacuum for
The analytical data were in accordance
2225,1770, 1635, 1585, 1550, 1490, 1435, 24 h.
1370, 1315, 1180, 1120, 1050, 1010, 975,
890, 870, 820, 760, 730, 700 590 cm–1. Cell Source and Culture Conditions
1H NMR (400 MHz, MeOD): δ = 7.64 (s,
Human fetal osteoblasts were derived
with the reported characterization.[13]
Preparation of Ligand 4
11,12-Didehydro-5,6-dihydrodi- 1H, CH), 3.39 (t, 2H, CH ), 2.92 (t, 1H, by the explant technique from the femo-
benzo[a,e][8]annulen-5-yl 4-nitrophenyl CH2), 2.30 (s, 9H, 3 CH3), 21.66 (m, 4H, 2 ral bone of a 12-week old fetus according
carbonate (2, 0.67 g, 1.7 mmol, 1 equiv.) CH2), 1.44 (m, 4H, 2 CH2). 13C NMR (101 to a protocol accepted by the Lausanne
was added to a solution of N-(2-{2-[2- MHz, MeOD): δ = 169.50, 168.35, 133.72, Hospital and University Ethics Committee
(2- aminoethoxy)ethoxy]ethoxy}ethyl)- 121.00, 40.81, 40.63, 30.1, 28.44, 27.32, and with the mother’s oral and written ap-
5-[(4R)-2-oxohexahydro-1H-thieno[3,4- 26.96, 20.38, 19.96. MS (ESI): HRMS proval (protocol No 51/01, 2008). These
d]imidazol-4-yl]pentanamide (3, 0.72 g, (ESI): (m/z): calcd for C19H26N2O7+H: cells were used at passage 6. Cells were
1.7 mmol, 1 equiv.) and triethylamine (0.7 395.1818, found: 395.1823.
mL, 5.2 mmol, 3 equiv.) in DMF (194 mL),
routinely grown in DMEM medium con-
taining 4.5 g/l glucose, 10% fetal calf
serum (FCS) and antibiotics (all from
under an argon atmosphere. The reaction
11,12-Didehydro-5,6-dihydrodi-
mixture was stirred overnight at rt, concen- benzo[a,e][8]annulen-5-yl(6- Invitrogen, Basel, Switzerland).
trated under reduced pressure and the resi- {[(3,4,5-trihydroxy phenyl)carbonyl]
due was purified by silica gel flash chroma- amino}hexyl) Carbamate (8)
Click Reaction on FsOs
tography (DCM/MeOH 98:2) to afford 4 as
5-[(6-aminohexyl)carbamoyl]ben-
l-Azidohomoalanine (AHA) was pur-
a green solid (225 mg, 20 %). IR (film): zene-1,2,3-triyl triacetate (7, 75 mg, 0.2 chased from Invitrogen, bovine serum
3330, 2920, 2865, 1780, 1705, 1520, 1450, mmol, 1 equiv.) was dissolved in DMF (18 albumin (BSA), from Sigma-Aldrich,
1330, 1205, 1075, 955, 925, 860, 815, 760, mL) and carbonic acid, 5,6-dihydro-11,12- Buchs, Switzerland. FsOs (80–90% con-
730, 685, 645, 565, 545, 520, 515 cm–1. didehydro-dibenzo[a, e]cycloocten-5-yl fluent) were washed with warm (37 °C)
1H-NMR(400 MHz, CDCl3): δ = 7.52 (d, ester, 4-nitrophenyl ester (2, 80 mg, 0.2 PBS and incubated in methionine-free
1H, aromatic, 2J = 7.6 Hz, CH (aromatic)), mmol, 1 equiv.), followed by triethylamine DMEM culture medium containing 4.5 g/L
7.41–7.26 (m, 7H, 7 CH (aromatics)), 5.50 (0.08 mL, 0.6 mmol, 3 equiv.) were added. glucose, antibiotics (P/S) and 3% FCS for
(s, 1H, CH), 4.47 (m, 1H, CH), 4.29 (m, The reaction mixture was stirred overnight
30–60 min to deplete methionine reserves.
1H, CH), 3.66–3.62 (m, 8H, 4 CH ), 3.60– at room temperature. DMF was removed Then they were incubated for 4 h in the
3.53 (m, 4H, 2 CH2), 3.47–3.36 2(m, 4H, under reduced pressure and the product presence of AHA (50 µM) in fresh com-
2 CH2), 3.19–3.09 (m, 2H, 2 CH), 2.96– was purified by flash column chromatog- plete culture medium. The culture medium
2.86 (m, 2H, 2 CH), 2.71 (d, 1H, 2J = 12.6 raphy (AcOEt/EP 1:1 then 2:1) (150 mg, was removed and the cell layer was washed
2
Hz, CH), 2.19 (t, 2H, J = 7.7 Hz, CH2), 46%). The resulting intermediate (33 mg,
twice with PBS.
Stock solution of compound 4 (2.5
2H, CH2). 13C-NMR (101 MHz, CDCl3): at 0 °C and a 1 M solution of LiOH (0.15 mM in PBS:DMF (7:3)) was prepared. For
δ = 172.8, 130.0, 128.1, 127.1, 126.1, mL, 0.15 mmol, 3 equiv.) was added. The microscopy experiments, the click reac-
123.8, 70.4, 70.1, 61.9, 60.3, 55.4, 46.2, reaction was monitored by MS until total tion was performed in a solution contain-
40.5, 39.2, 29.7, 28.0, 25.6, 25.4. HRMS conversion of the starting material. The ing compound 4 (20–100 µM) in DMEM
1.70–1.60 (m, 4H, 2 CH2), 1.45–1.40 (m, 0.05 mmol, 1 equiv.) was dissolved in THF